trodelvy
gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - agenți antineoplazici - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.
ketoprofen pharmexon 25 mg
abiogen pharma s.p.a. - italia - ketoprofenum - compr. film. - 25mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic
ketoprofen pharmexon 25 mg
dompe farmaceutici s.p.a. - italia - ketoprofenum - granule drajefiate in plic - 25mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic
mounjaro
eli lilly nederland b.v. - tirzepatide - diabetul zaharat, tip 2 - medicamente utilizate în diabet - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 și 5.
ketoprofen pharmexon 25 mg
abiogen pharma s.p.a. - italia - ketoprofenum - compr. film. - 25mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic
ketoprofen pharmexon 25 mg
dompe farmaceutici s.p.a. - italia - ketoprofenum - granule drajefiate in plic - 25mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic
hemgenix
csl behring gmbh - etranacogene dezaparvovec - hemofilia b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glicogenul de boală de tip ii - alte medicamente pentru tractul digestiv și metabolism, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).
tyruko
sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresoare - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 și 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.
ciprofloxacin comprimate filmate 250 mg
sc new tone srl - ciprofloxacinum - comprimate filmate - 250 mg